Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases

Molecular and Cellular Neuroscience

Volumn 25, Issue 3, 2004, Pages 493-503

  Bailey, Craig D C ^a   Graham, Robert M ^b   Nanda, Nisha ^b   Davies, Peter J A ^c   Johnson, Gail V W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FOREBRAIN; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS;

AGED; AGED, 80 AND OVER; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; PROSENCEPHALON; TRANSGLUTAMINASES;

EID: 1642336449     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.11.016     Document Type: Article

References (70)

1. Achyuthan K.E., Greenberg C.S. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J. Biol. Chem. 262:1987;1901-1906.
2. Aeschlimann D., Wetterwald A., Fleisch H., Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J. Cell Biol. 120:1993;1461-1470.
3. Ahvazi B., Boeshans K.M., Idler W., Baxa U., Steinert P.M., Rastinejad F. Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium. J. Biol. Chem. 2004;. In press.
4. Birckbichler P.J., Orr G.R., Patterson M.K. Jr., Conway E., Carter H.A. Increase in proliferative markers after inhibition of transglutaminase. Proc. Natl. Acad. Sci. U. S. A. 78:1981;5005-5008.
5. Buommino E., Pasquali D., Sinisi A.A., Bellastella A., Morelli F., Metafora S. Sodium butyrate/retinoic acid costimulation induces apoptosis-independent growth arrest and cell differentiation in normal and ras-transformed seminal vesicle epithelial cells unresponsive to retinoic acid. J. Mol. Endocrinol. 24:2000;83-94.
6. Chen S., Lin F., Iismaa S., Lee K.N., Birckbichler P.J., Graham R.M. Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J. Biol. Chem. 271:1996;32385-32391.
7. Chun W., Lesort M., Tucholski J., Faber P.W., MacDonald M.E., Ross C.A., Johnson G.V. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells. Neurobiol. Dis. 8:2001;391-404.
8. Chun W., Lesort M., Tucholski J., Ross C.A., Johnson G.V. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates. J. Cell Biol. 153:2001;25-34.
9. Citron B.A., SantaCruz K.S., Davies P.J., Festoff B.W. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J. Biol. Chem. 276:2001;3295-3301.
10. Citron B.A., Suo Z., SantaCruz K., Davies P.J., Qin F., Festoff B.W. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem. Int. 40:2002;69-78.
11. Cooper A.J., Sheu K.F., Burke J.R., Onodera O., Strittmatter W.J., Roses A.D., Blass J.P. Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases? J. Neurochem. 69:1997;431-434.
12. Dedeoglu A., Kubilus J.K., Jeitner T.M., Matson S.A., Bogdanov M., Kowall N.W., Matson W.R., Cooper A.J., Ratan R.R., Beal M.F., Hersch S.M., Ferrante R.J. Therapeutic effects of cystamine in a murine model of Huntington's disease. J. Neurosci. 22:2002;8942-8950.
13. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
14. Dudek S.M., Johnson G.V. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble. Alz-50-reactive polymers of tau. J. Neurochem. 61:1993;1159-1162.
15. Dudek S.M., Johnson G.V. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res. 651:1994;129-133.
16. Feigin A., Zgaljardic D. Recent advances in Huntington's disease: implications for experimental therapeutics. Curr. Opin. Neurol. 15:2002;483-489.
17. Festoff B.W., SantaCruz K., Arnold P.M., Sebastian C.T., Davies P.J., Citron B.A. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. J. Neurochem. 81:2002;708-718.
18. Fesus L., Thomazy V., Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:1987;104-108.
19. Gentile V., Saydak M., Chiocca E.A., Akande O., Birckbichler P.J., Lee K.N., Stein J.P., Davies P.J. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J. Biol. Chem. 266:1991;478-483.
20. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:1991;3071-3077.
21. Haroon Z.A., Hettasch J.M., Lai T.S., Dewhirst M.W., Greenberg C.S. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 13:1999;1787-1795.
22. Hiiragi T., Sasaki H., Nagafuchi A., Sabe H., Shen S.C., Matsuki M., Yamanishi K., Tsukita S. Transglutaminase type 1 and its cross-linking activity are concentrated at adherens junctions in simple epithelial cells. J. Biol. Chem. 274:1999;34148-34154.
23. Hitomi K., Horio Y., Ikura K., Yamanishi K., Maki M. Analysis of epidermal-type transglutaminase (TGase 3) expression in mouse tissues and cell lines. Int. J. Biochem. Cell Biol. 33:2001;491-498.
24. Ho G.J., Gregory E.J., Smirnova I.V., Zoubine M.N., Festoff B.W. Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase. FEBS Lett. 349:1994;151-154.
25. Ientile R., Caccamo D., Macaione V., Torre V., Macaione S. NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells. Neuroscience. 115:2002;723-729.
26. Ikura K., Takahata K., Sasaki R. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase. FEBS Lett. 326:1993;109-111.
27. Jeitner T.M., Bogdanov M.B., Matson W.R., Daikhin Y., Yudkoff M., Folk J.E., Steinman L., Browne S.E., Beal M.F., Blass J.P., Cooper A.J. N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. J. Neurochem. 79:2001;1109-1112.
28. Johnson G.V., Cox T.M., Lockhart J.P., Zinnerman M.D., Miller M.L., Powers R.E. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751:1997;323-329.
29. Junn E., Ronchetti R.D., Quezado M.M., Kim S.Y., Mouradian M.M. Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 100:2003;2047-2052.
30. Kahlem P., Green H., Djian P. Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol. Cell. 1:1998;595-601.
31. Karpuj M.V., Garren H., Slunt H., Price D.L., Gusella J., Becher M.W., Steinman L. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7388-7393.
32. Karpuj M.V., Becher M.W., Springer J.E., Chabas D., Youssef S., Pedotti R., Mitchell D., Steinman L. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat. Med. 8:2002;143-149.
33. Katoh S., Nakagawa N., Yano Y., Satoh K., Kohno H., Ohkubo Y., Suzuki T., Kitani K. Hepatocyte growth factor induces transglutaminase activity that negatively regulates the growth signal in primary cultured hepatocytes. Exp. Cell Res. 222:1996;255-261.
34. Kim S.Y., Grant P., Lee J.H., Pant H.C., Steinert P.M. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J. Biol. Chem. 274:1999;30715-30721.
35. Lesort M., Chun W., Johnson G.V., Ferrante R.J. Tissue transglutaminase is increased in Huntington's disease brain. J. Neurochem. 73:1999;2018-2027.
36. Lesort M., Lee M., Tucholski J., Johnson G.V. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J. Biol. Chem. 278:2003;3825-3830.
37. Lin C.H., Tallaksen-Greene S., Chien W.M., Cearley J.A., Jackson W.S., Crouse A.B., Ren S., Li X.J., Albin R.L., Detloff P.J. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 10:2001;137-144.
38. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev., Mol. Cell Biol. 4:2003;140-156.
39. Lu S., Saydak M., Gentile V., Stein J.P., Davies P.J. Isolation and characterization of the human tissue transglutaminase gene promoter. J. Biol. Chem. 270:1995;9748-9756.
40. Maccioni R.B., Seeds N.W. Transglutaminase and neuronal differentiation. Mol. Cell. Biochem. 69:1986;161-168.
41. Maggio N., Sellitti S., Capano C.P., Papa M. Tissue-transglutaminase in rat and human brain: light and electron immunocytochemical analysis and in situ hybridization study. Brain Res. Bull. 56:2001;173-182.
42. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
43. Mastroberardino P.G., Iannicola C., Nardacci R., Bernassola F., De Laurenzi V., Melino G., Moreno S., Pavone F., Oliverio S., Fesus L., Piacentini M. 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ. 9:2002;873-880.
44. McMurray C.T. Huntington's disease: new hope for therapeutics. Trends Neurosci. 24:2001;S32-S38.
45. Melino G., Annicchiarico-Petruzzelli M., Piredda L., Candi E., Gentile V., Davies P.J., Piacentini M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell. Biol. 14:1994;6584-6596.
46. Menalled L.B., Sison J.D., Wu Y., Olivieri M., Li X.J., Li H., Zeitlin S., Chesselet M.F. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J. Neurosci. 22:2002;8266-8276.
47. Miller M.L., Johnson G.V. Transglutaminase cross-linking of the tau protein. J. Neurochem. 65:1995;1760-1770.
48. Murthy S.N., Wilson J.H., Lukas T.J., Kuret J., Lorand L. Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase. J. Neurochem. 71:1998;2607-2614.
49. Nagy L., Saydak M., Shipley N., Lu S., Basilion J.P., Yan Z.H., Syka P., Chandraratna R.A., Stein J.P., Heyman R.A., Davies P.J. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 271:1996;4355-4365.
50. Nagy L., Thomazy V.A., Saydak M.M., Stein J.P., Davies P.J. The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression. Cell Death Differ. 4:1997;534-547.
51. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., Im M.J., Graham R.M. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 264:1994;1593-1596.
52. Nanda N., Iismaa S.E., Owens W.A., Husain A., Mackay F., Graham R.M. Targeted inactivation of Gh/tissue transglutaminase II. J. Biol. Chem. 276:2001;20673-20678.
53. Ohashi H., Itoh Y., Birckbichler P.J., Takeuchi Y. Purification and characterization of rat brain transglutaminase. J. Biochem. (Tokyo). 118:1995;1271-1278.
54. Oliverio S., Amendola A., Rodolfo C., Spinedi A., Piacentini M. Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J. Biol. Chem. 274:1999;34123-34128.
55. Pastuszko A., Wilson D.F., Erecinska M. A role for transglutaminase in neurotransmitter release by rat brain synaptosomes. J. Neurochem. 46:1986;499-508.
56. Perry M.J., Haynes L.W. Localization and activity of transglutaminase, a retinoid-inducible protein, in developing rat spinal cord. Int. J. Dev. Neurosci. 11:1993;325-337.
57. Perry M.J., Mahoney S.A., Haynes L.W. Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking. Neuroscience. 65:1995;1063-1076.
58. Piacentini M., Fesus L., Farrace M.G., Ghibelli L., Piredda L., Melino G. The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur. J. Cell Biol. 54:1991;246-254.
59. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J.L., Melino E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer. 52:1992;271-278.
60. Piacentini M., Farrace M.G., Piredda L., Matarrese P., Ciccosanti F., Falasca L., Rodolfo C., Giammarioli A.M., Verderio E., Griffin M., Malorni W. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J. Neurochem. 81:2002;1061-1072.
61. Sardy M., Karpati S., Merkl B., Paulsson M., Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med. 195:2002;747-757.
62. Shelbourne P.F., Killeen N., Hevner R.F., Johnston H.M., Tecott L., Lewandoski M., Ennis M., Ramirez L., Li Z., Iannicola C., Littman D.R., Myers R.M. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8:1999;763-774.
63. Szegezdi E., Szondy Z., Nagy L., Nemes Z., Friis R.R., Davies P.J., Fesus L. Apoptosis-linked in vivo regulation of the tissue transglutaminase gene promoter. Cell Death Differ. 7:2000;1225-1233.
64. Takeuchi Y., Birckbichler P.J., Patterson M.K. Jr., Lee K.N. Putative nucleotide binding sites of guinea pig liver transglutaminase. FEBS Lett. 307:1992;177-180.
65. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
66. Tolentino P.J., DeFord S.M., Notterpek L., Glenn C.C., Pike B.R., Wang K.K., Hayes R.L. Up-regulation of tissue-type transglutaminase after traumatic brain injury. J. Neurochem. 80:2002;579-588.
67. Tucholski J., Johnson G.V. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J. Neurochem. 81:2002;780-791.
68. Tucholski J., Lesort M., Johnson G.V. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience. 102:2001;481-491.
69. Tunici P., Sessa A., Rabellotti E., Calloni A., Perin A. Distribution and activity of transglutaminase in rat brain carcinogenesis and in gliomas. Cancer Lett. 140:1999;47-51.
70. Zemaitaitis M.O., Kim S.Y., Halverson R.A., Troncoso J.C., Lee J.M., Muma N.A. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 62:2003;173-184.